generic glp 1 agonists Diabetes patients now have access to first GLP-1 medication: ‘More accessible and affordable’ GLP- 1 Agonist Therapy Center

This indicates that differences between species may influence outcomes, despite using the same concentration range

While its effective for blood sugar control, its weight loss results are modest compared to newer options

Several mechanisms may be involved in this potential association, some of which include sudden weight loss and hyperactivity of the hypothalamic-pituitary-adrenal axis

In a diabetic kidney disease (DKD) model, liraglutide was demonstrated to enhance renal outcomes through the modulation of gut microbiota composition and the elevation of circulating levels of L-5-Oxoproline (5-OP)

More recently, a phase IIb study in AD ( n = 206) reported 12 months of treatment with liraglutide slowed cognitive decline (ADAS-EXEC) by approximately 18% and attenuated cortical atrophy by approximately 50% (140)